Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Prieto

Showing results (151-160 of 476) with videos related to

Pageof 48
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2014
Oral bisphosphonate use and total knee/hip implant survival: validation of results in an external population-based cohortDaniel Prieto-Alhambra, Arief Lalmohamed, Bo Abrahamsen, et al.
Clinical Epidemiology|November 17, 2022
Validation of Algorithms to Identify Acute Myocardial Infarction, Stroke, and Cardiovascular Death in German Health Insurance DataKatharina Platzbecker, Annemarie Voss, Jonas Reinold, et al.
Journal of the American Geriatrics Society|October 31, 2023
Cholinesterase inhibitors and non-steroidal anti-inflammatory drugs and the risk of peptic ulcers: A self-controlled studyMáté Szilcz, Jonas W Wastesson, Amaia Calderón-Larrañaga, et al.
Age and Ageing|December 19, 2021
Development and validation of a model for predicting mortality in patients with hip fractureThomas J Hjelholt, Søren P Johnsen, Peter K Brynningsen, et al.
BMJ Open|February 17, 2022
Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients' satisfaction: a cross-sectional survey by patient organisationsKayoko Kaneko, Daniel Prieto-Alhambra, Clare Jacklin, et al.
Age and Ageing|August 20, 2025
Longitudinal trajectories of polypharmacy in older people, and their association with the risk of mortality: a joint latent class model analysis of real-world data from the UK and the NetherlandsLeena Elhussein, Ross D Williams, Wai Yi Man, et al.
Osteoarthritis and Cartilage Open|December 7, 2022
Does osteoarthritis modify the association between NSAID use and risk of comorbidities and adverse events?Andrea Dell'Isola, Aleksandra Turkiewicz, Weiya Zhang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 7, 2018
Differential Mortality and the Excess Rates of Hip Fracture Associated With Type 2 Diabetes: Accounting for Competing Risks in Fracture Prediction MattersCristian Tebé, Daniel Martinez-Laguna, Victor Moreno, et al.
Rheumatology (Oxford, England)|October 5, 2017
Population trends in the incidence and initial management of osteoarthritis: age-period-cohort analysis of the Clinical Practice Research Datalink, 1992-2013Dahai Yu, Kelvin P Jordan, John Bedson, et al.
Rheumatology (Oxford, England)|April 15, 2021
Corrigendum to: Higher prevalence of non-skeletal comorbidity related to X-linked hypophosphataemia: a UK parallel cohort study using CPRDSamuel Hawley, Nick J Shaw, Antonella Delmestri, et al.
Pageof 48

Showing results (151-160 of 476) with videos related to

Sort By:
Pageof 48
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2014
Oral bisphosphonate use and total knee/hip implant survival: validation of results in an external population-based cohortDaniel Prieto-Alhambra, Arief Lalmohamed, Bo Abrahamsen, et al.
Clinical Epidemiology|November 17, 2022
Validation of Algorithms to Identify Acute Myocardial Infarction, Stroke, and Cardiovascular Death in German Health Insurance DataKatharina Platzbecker, Annemarie Voss, Jonas Reinold, et al.
Journal of the American Geriatrics Society|October 31, 2023
Cholinesterase inhibitors and non-steroidal anti-inflammatory drugs and the risk of peptic ulcers: A self-controlled studyMáté Szilcz, Jonas W Wastesson, Amaia Calderón-Larrañaga, et al.
Age and Ageing|December 19, 2021
Development and validation of a model for predicting mortality in patients with hip fractureThomas J Hjelholt, Søren P Johnsen, Peter K Brynningsen, et al.
BMJ Open|February 17, 2022
Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients' satisfaction: a cross-sectional survey by patient organisationsKayoko Kaneko, Daniel Prieto-Alhambra, Clare Jacklin, et al.
Age and Ageing|August 20, 2025
Longitudinal trajectories of polypharmacy in older people, and their association with the risk of mortality: a joint latent class model analysis of real-world data from the UK and the NetherlandsLeena Elhussein, Ross D Williams, Wai Yi Man, et al.
Osteoarthritis and Cartilage Open|December 7, 2022
Does osteoarthritis modify the association between NSAID use and risk of comorbidities and adverse events?Andrea Dell'Isola, Aleksandra Turkiewicz, Weiya Zhang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 7, 2018
Differential Mortality and the Excess Rates of Hip Fracture Associated With Type 2 Diabetes: Accounting for Competing Risks in Fracture Prediction MattersCristian Tebé, Daniel Martinez-Laguna, Victor Moreno, et al.
Rheumatology (Oxford, England)|October 5, 2017
Population trends in the incidence and initial management of osteoarthritis: age-period-cohort analysis of the Clinical Practice Research Datalink, 1992-2013Dahai Yu, Kelvin P Jordan, John Bedson, et al.
Rheumatology (Oxford, England)|April 15, 2021
Corrigendum to: Higher prevalence of non-skeletal comorbidity related to X-linked hypophosphataemia: a UK parallel cohort study using CPRDSamuel Hawley, Nick J Shaw, Antonella Delmestri, et al.
Pageof 48